These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 11586277)

  • 1. Antibody-directed therapy: past, present, and future.
    Gelfand EW
    J Allergy Clin Immunol; 2001 Oct; 108(4 Suppl):S111-6. PubMed ID: 11586277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and use of therapeutic antibodies primarily of human origin.
    Stiehm ER; Keller MA; Vyas GN
    Biologicals; 2008 Nov; 36(6):363-74. PubMed ID: 18789721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
    Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
    Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravenous immunoglobulin therapy].
    Mouthon L
    Rev Prat; 2005 May; 55(10):1049-56. PubMed ID: 16097244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IVIG in autoimmune disease - Potential next generation biologics.
    Zuercher AW; Spirig R; Baz Morelli A; Käsermann F
    Autoimmun Rev; 2016 Aug; 15(8):781-5. PubMed ID: 27019051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indications and mechanisms of action of the intravenous immunoglobulines in the systemic autoimmune and inflammatory pathologies].
    Mouthon L; Bussone G; Kaveri S
    Rev Med Interne; 2009 Dec; 30(12 Suppl):H14-20. PubMed ID: 19995651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy with immunoglobulins].
    Müller E; Zabel P
    Immun Infekt; 1990 Oct; 18(5):162-3. PubMed ID: 2265862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations.
    Späth PJ; Schneider C; von Gunten S
    Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):215-231. PubMed ID: 27638480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotherapy in non-allergic diseases].
    Español T
    Allergol Immunopathol (Madr); 2000; 28(3):107-9. PubMed ID: 10867379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunomodulatory effects of intravenous immunoglobulins].
    Kazatchkine M; Mouthon L; Kaveri SV
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S13-8. PubMed ID: 10896983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a high-affinity monoclonal antibody.
    Bazin R; Lemieux R; Tremblay T
    Br J Haematol; 2006 Oct; 135(1):97-100. PubMed ID: 16925577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Southwestern Internal Medicine Conference: high-dose intravenous gamma globulin therapy: how does it work?
    Smiley JD; Talbert MG
    Am J Med Sci; 1995 May; 309(5):295-303. PubMed ID: 7733144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7th International Immunoglobulin Conference: Mechanisms of action.
    Basta M; Branch DR
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):111. PubMed ID: 25546783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expanding role of therapeutic antibodies.
    Salemi S; Markovic M; Martini G; D'Amelio R
    Int Rev Immunol; 2015 May; 34(3):202-64. PubMed ID: 24471447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7(th) International Immunoglobulin Conference: Poster presentations.
    Warnatz K; Ballow M; Stangel M; Bril V
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):139-40. PubMed ID: 25546796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The other side of immunoglobulin G: suppressor of inflammation.
    Aschermann S; Lux A; Baerenwaldt A; Biburger M; Nimmerjahn F
    Clin Exp Immunol; 2010 May; 160(2):161-7. PubMed ID: 20041883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency.
    Berger M
    Immunol Allergy Clin North Am; 2008 May; 28(2):413-37, x. PubMed ID: 18424340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin therapy.
    Stein LD; Roifman CM
    Bull Rheum Dis; 1995 Jun; 44(4):3-5. PubMed ID: 7787963
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic measures in immunology].
    Russo L
    Minerva Anestesiol; 1978 Oct; 44(10):737-79. PubMed ID: 375127
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current developments in the use of intravenous immunoglobulins].
    Bardare M; Dellepiane RM
    Minerva Pediatr; 1991 Nov; 43(11):665-74. PubMed ID: 1791793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.